Last reviewed · How we verify

NCT04662047: ONAIR

The Impact of Air Pollution on the Consumption of Antimicrobials in the General Population

Status unknown Last updated 25 January 2023
What this trial tests

trial in Community-acquired Pneumonia in 3,249,128 participants. Status unknown.

Timeline
1 January 2021
Primary endpoint
31 December 2023
31 December 2023

Quick facts

Lead sponsorHospital Universitari de Bellvitge
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment3,249,128
Start date1 January 2021
Primary completion31 December 2023
Estimated completion31 December 2023
Sites1 location across Spain

Conditions studied

Sponsor

Hospital Universitari de Bellvitge

Who can join

Eligibility, any sex, with Community-acquired Pneumonia or Air Pollution. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objectives: To test the hypothesis that certain levels of air pollution may lead to increases in 1) antimicrobial consumption in the general population and 2) the presence of antibiotic resistance genes. Methods: The project will consist of two sub-studies: 1. A time series analysis of the association between daily antimicrobial consumption and air pollution in the 11 largest cities in Catalonia (2006-2022). Outcome variable: daily consumption of antimicrobials. Independent variables: air pollution and confounding variables. The analysis will use generalized additive models: through a random effects meta-analysis, the concentration-response estimates for each city will be added together to calculate the overall estimates. 2. Descriptive observational study of the relationship between the concentration of resistance genes and antimicrobial consumption in the Barcelona area (2021-2023). Outcome variable: concentration of antibiotic resistance genes. Independent variables: defined daily dose of antimicrobials per 1000 inhabitants-day. Descriptive analysis of the concentration and diversity of antibiotic resistance genes according to air quality monitoring station (urban vs. hospital environment), month, and correlation with antimicrobial consumption.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Short-Term Exposure to Ambient Air Pollution and Antimicrobial Use for Acute Respiratory Symptoms.
    Abelenda-Alonso G, Satorra P, Marí-Dell'Olmo M, Tebé C, et al · · 2024 · cited 7× · PMID 39240563 · DOI 10.1001/jamanetworkopen.2024.32245

Verify or expand the search:

Other recruiting trials for Community-acquired Pneumonia

Currently open trials in the same condition.

Other Hospital Universitari de Bellvitge trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04662047.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing